VA Cultivating Access to Resources, Education, and Skills for Dementia Caregivers (VACARES)
20. juli 2021 oppdatert av: VA Office of Research and Development
Dementia Caregiver Rehabilitation: Enhancing Veteran and Family-Centered Care
The purpose of this study is to study the effects of an education and skill-building intervention on family caregivers of Veterans with dementia.
Studieoversikt
Status
Fullført
Intervensjon / Behandling
Detaljert beskrivelse
According to VA estimates, nearly 500,000 Veterans suffer from dementia.
There is currently no cure for dementia.
Ultimately, dementia will have a large impact on quality of life in Veterans and families, lead to expensive nursing home placement, and decrease life expectancy for patients and family caregivers.
The experience of high burden in a caregiver for a Veteran with dementia increases the likelihood of permanent nursing home placement and can separate Veterans from their families.
To address the high burden of caring for a Veteran with dementia, the investigators aim to study the effect of a rehabilitative intervention for family caregivers of Veterans with dementia.
This novel approach will use video technology that can reach caregivers in rural areas who do not have easy access to major VA medical centers.
Studietype
Intervensjonell
Registrering (Faktiske)
32
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
California
-
Palo Alto, California, Forente stater, 94304-1290
- VA Palo Alto Health Care System, Palo Alto, CA
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
Inclusion criteria -- Participants must:
- be adults (age 18)
- report distress associated with being the primary caregiver for a Veteran family member with all-cause dementia
- reporting at least 2 of the following 6 items at baseline assessment: felt overwhelmed, felt like they often needed to cry, were angry or frustrated, felt they were cut off from family or friends, reported moderate to high levels of general stress, or felt their health had declined
- provide at least one hour of care (supervision or direct assistance) per week over the past 3 months (other sources of caregiving for the Veteran with dementia can also be utilized; e.g., respite, home health aide, other family members, etc.)
- be proficient in spoken and written English
- be capable of providing informed consent
Exclusion Criteria:
Exclusion criteria -- Potential participants will be screened and excluded for:
- current or lifetime history of any psychiatric disorder with psychotic features
- prominent suicidal or homicidal ideation
- having met DSM-IV criteria for drug or alcohol abuse or dependence (except nicotine) within the past six months
- presence of alcohol intoxication (by breathalyzer) or alcohol withdrawal (by exam) during study recruitment or participation
- diagnosis of probable or possible dementia
- a Telephone Cognitive Screen score of < 20
- participation in another caregiver intervention within the past year
- lack of regular access to a telephone
- illness that would prevent 24 months of study participation
- planned transfer of care receiver to another caregiver or nursing home within 12 months
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: In-person Education and Skill-Building Rehabilitation (ESBR-i) Condition
Education and Skill-Building Rehabilitation delivered in clinic
|
ESBR intervention consists of four, 90-minute sessions over a 4-6 week period.
These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention.
Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.
Andre navn:
|
|
Eksperimentell: Education and Skill-Building Rehabilitation over Video (ESBR-V) Condition
Education and Skill-Building Rehabilitation delivered via video telehealth.
|
ESBR intervention consists of four, 90-minute sessions over a 4-6 week period.
These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention.
Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.
Andre navn:
|
|
Aktiv komparator: Usual Care Condition
Usual Care plus supplemental paper education materials
|
Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Zarit Burden Inventory
Tidsramme: change from baseline at 6-months post intervention
|
The Zarit Burden Inventory is a self-report measure of caregiver burden.
Higher scores on this assessment indicate greater levels of caregiver burden.
Potential scores range from 0-88 with higher scores indicating more severe burden.
|
change from baseline at 6-months post intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Center for Epidemiological Studies-Depression
Tidsramme: change from baseline at 6-months
|
change in caregiver depressive symptoms as measured by the Center for Epidemiological Studies-Depression (CES-D).
Scores on the CES-D can range from 0-60 with higher scores suggesting greater depressive symptomatology.
|
change from baseline at 6-months
|
|
Long-term Care Placement Status (Care Recipient)
Tidsramme: 6-months post intervention
|
Based on caregiver interview, permanent placement of the care recipient in LTC will be ascertained
|
6-months post intervention
|
|
Change in All-cause Mortality Status (Care Recipient)
Tidsramme: 6-months post intervention
|
Based on caregiver interview, care recipient mortality status will be ascertained
|
6-months post intervention
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Blake K Scanlon, PhD, VA Palo Alto Health Care System, Palo Alto, CA
- Hovedetterforsker: Jennifer K Fairchild, PhD, VA Palo Alto Health Care System, Palo Alto, CA
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
21. februar 2014
Primær fullføring (Faktiske)
30. september 2019
Studiet fullført (Faktiske)
30. september 2019
Datoer for studieregistrering
Først innsendt
27. mars 2014
Først innsendt som oppfylte QC-kriteriene
2. april 2014
Først lagt ut (Anslag)
7. april 2014
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
13. august 2021
Siste oppdatering sendt inn som oppfylte QC-kriteriene
20. juli 2021
Sist bekreftet
1. juli 2021
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- E1240-W
- 5IK2RX001240-02 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .